Where a woman gives birth shouldn’t determine her fate, but too often it does. PATH is finding new ways to keep women safe during childbirth, no matter where they are.
In conjunction with the UN General Assembly in New York last month, PATH released a policy report that offers a targeted agenda for increasing the quality and availability of three maternal health medicines. We also debuted a photo exhibit of women with and without access to adequate health care. And in collaboration with Merck for Mothers, we’re working to advance innovative technologies to reduce maternal mortality.
Learn more about PATH’s work in maternal health on our website.
Shining a spotlight on female condoms. In celebration of Global Female Condom Day, PATH hosted a fashion show that featured female condoms with creative flair and delivered a call to action to expand these tools to more women and men.
We’re exceeding our meningitis commitment, PATH’s CEO says. PATH is continuing to provide people in Africa’s meningitis belt with a lifesaving vaccine against meningitis A, president and CEO Steve Davis said last month at the annual meeting of the Clinton Global Initiative. Watch his video on our blog.
Phone-based system could keep vaccines in stock. Project Optimize—a partnership between PATH and the World Health Organization—is working with UNICEF and the South Sudan government to test a new system that uses mobile phones to manage vaccine supplies. Supply managers use the system to monitor their stock and ensure health centers have enough vaccine. Read more in the October 2012 issue of Op.ti.mize.
Project makes headway in improving child health. In September, South African health leaders joined PATH and our donor, BHP Billiton Sustainable Communities, to celebrate progress in the Window of Opportunity project. Under the five-year initiative, we are assessing communities’ maternal and child health and development needs in South Africa and Mozambique and partnering with stakeholders to create targeted interventions. New project briefs describe progress in four South African districts.
RSV maternal vaccine study advances. A candidate vaccine for respiratory syncytial virus (RSV), a major cause of respiratory illness in children, has moved into a phase 2 clinical trial in the United States. If the PATH-supported vaccine ultimately proves successful, it could be given to pregnant women to protect their children from the virus.
Training strengthens fight against tuberculosis (TB) in Zambia. PATH staff members and activist Carol Nyirenda, leader of the PATH-supported Africa Coalition on Tuberculosis (ACT!), trained members of Zambian civil-society groups in advocacy, communication, and social mobilization to enhance the country’s TB control efforts. The training linked participants with Zambia’s National TB and Leprosy Program and helped establish the coalition’s Zambia branch.
A fact sheet describes PATH’s new drug development program.
A new website describes how PATH expands developing countries’ access to lifesaving rotavirus vaccines and provides technical, advocacy, and communications resources about rotavirus disease and vaccines.
An advocacy and communications toolkit offers resources for introducing rotavirus vaccines and sustaining their implementation.
A case study details PATH’s landmark public-private partnership to develop the vaccine vial monitor.
A fact sheet provides an overview of PATH’s efforts to develop evidence-based programs for diabetes prevention and control.
A fact sheet and project brief describe PATH’s work to strengthen the role of pharmacies across Vietnam to provide primary health services.
A fact sheet in our Technology Updates series describes PATH’s work to reduce household air pollution from cookstoves. Browse the list to see all 55 updates in this series.
A fact sheet describes PATH’s work to develop a vaccine against respiratory syncytial virus for the developing world.
A report prepared by PATH and our partners, available on the Maternal and Child Health Integrated Program website, evaluates the acceptability and feasibility of introducing oxytocin in the Uniject™ inject system to prevent postpartum hemorrhage in Honduras.
View these new resources and more in our online publications catalog.
Global initiative stresses lifesaving supplies for women and children. PATH will help convene expert groups to implement critical recommendations outlined in a new report from the UN Commission on Life-Saving Commodities for Women and Children. We played a pivotal role in the report's inclusion of recommendations to improve women’s and children’s access to health supplies—such as our Woman’s Condom—and reduce inequities in health.
Uniject is a trademark of BD.
